Latest News

Revance is a biotechnology company focused on innovative aesthetic and therapeutic offerings, as well as financial technology services for aesthetic practices.


Governor Lee, Commissioner Rolfe Announce Revance Therapeutics to Relocate Global Headquarters to Nashville

Nash Business Journal logo

Nashville Business Journal: Revance Therapeutics moves HQ from California to Nashville; CEO counting on ability to recruit to fill 150 jobs 

Scrip Logo

Revance Builds Therapeutics Credibility For DaxibotulinumtoxinA Ahead Of Aesthetics Launch 

Healio Logo

DaxibotulinumtoxinA for injection shows consistent efficacy in open-label study

MDEdge Logo

Novel botulinum toxin type A earns high marks for forehead lines

Aesthetic Authority Logo

Revance Reports Positive Results in Two Phase 2a Studies of DAXI

Medium Logo

Dustin S. Sjuts of Revance Therapeutics: Five Things You Need To Know To Succeed In The Modern Beauty Industry

Neurology Live Logo

DaxibotulinumtoxinA Aims to Be Next Big Post-Stroke Spasticity Treatment

Bloomberg Logo

Bloomberg: Revance Completes Previously Announced Acquisition of HintMD and its Proprietary Fintech Platform for Aesthetic Practices

Modern Aesthetics logo

Modern Aesthetics: Revance’s DaxibotulinumtoxinA for Injection Looks Good in Phase 2 Studies of Forehead Lines and Crow’s Feet